ContraFect Corporation (CFRX)
ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.
Address New York
Microbiology Product Areas
ClinicalNOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated.
|Antibiotic Resistance||Show all suppliers|
|Antimicrobial Resistance (AMR)||Show all suppliers|